LBO2 Long-term renal and cardiovascular risks of tacrolimus in lupus nephritis patients

• Obbo W Bredewold,
• Ton J Rabelink,
• YK Onno Teng,
• Joris I Rotmans,
• Mieke van Schaik,
• Merel Priester,
• Wieneke M Michels

Affiliations

Obbo W Bredewold

1Center of Expertise for Lupus, Vasculitis and Complement-mediated Systemic disease (LuVaCs), Dept. of Nephrology, Leiden University Medical Center, Leiden, The Netherlands

Ton J Rabelink

Department of Nephrology, Leiden University Medical Centre

YK Onno Teng

Leiden University Medical Center (LUMC), the Netherlands

Joris I Rotmans

Department of Internal Medicine, Leiden University Medical Centre, Leiden, Netherlands

Mieke van Schaik

1Center of Expertise for Lupus, Vasculitis and Complement-mediated Systemic disease (LuVaCs), Dept. of Nephrology, Leiden University Medical Center, Leiden, The Netherlands

Merel Priester

1Center of Expertise for Lupus, Vasculitis and Complement-mediated Systemic disease (LuVaCs), Dept. of Nephrology, Leiden University Medical Center, Leiden, The Netherlands

Wieneke M Michels

2Dept. of Nephrology, Leiden University Medical Center, Leiden, The Netherlands